肝MRI中钆匹醇与钆贝葡胺的个体内比较:对强化效率的影响
单中心回顾性研究纳入71例患者,个体内比较肝MRI中钆匹醇(0.05 mmol/kg)与钆贝葡胺(0.1 mmol/kg)的肝脏强化。两种对比剂在3分钟和5分钟时肝脏强化程度无显著差异(P>0.3),但钆匹醇每毫升钆的强化效率显著更高(P<0.001)。结论认为钆匹醇单位体积强化效率更高,而标准剂量下总体强化相似。
要点
- 钆匹醇0.05 mmol/kg与钆贝葡胺0.1 mmol/kg在3分钟和5分钟肝脏强化程度无显著差异(P>0.3)。
- 钆匹醇每毫升钆的肝脏强化效率在3分钟和5分钟均显著高于钆贝葡胺(P<0.001)。
- 钆匹醇平均用量8±1.7 ml,钆贝葡胺平均用量16±3.5 ml。
核心结论
- 钆匹醇单位体积强化效率高于钆贝葡胺,但标准剂量下总体肝脏强化程度相似。
研究设计与样本
- 单中心回顾性研究,纳入71例在2023年9月至2023年12月期间接受钆匹醇增强肝MRI的患者,并包含18个月内钆贝葡胺增强肝MRI作为比较。钆匹醇注射剂量0.05 mmol/kg(0.1 ml/kg),钆贝葡胺0.1 mmol/kg(0.2 ml/kg)。由两名腹部影像亚专业放射科医生独立测量平扫、增强后3分钟和5分钟肝实质信号强度。
诊断标准与关键数值
- 肝脏强化(LE)计算公式为(增强后SI-平扫SI)/平扫SI×100%。每毫升钆的肝脏强化(LE/ml)为LE除以所用对比剂毫升数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To perform an intraindividual comparison of hepatic enhancement on MRI after gadopiclenol versus gadobenate dimeglumine administration.
MATERIALS AND METHODS: This single-center retrospective study included 71 patients who underwent gadopiclenol-enhanced MR imaging of the liver between September 2023 and December 2023. Patients with a comparison gadobenate dimeglumine-enhanced MRI of the liver within 18 months of the gadopiclenol-enhanced study were included. Gadopiclenol was injected at 0.05 mmol/kg (0.1 ml/kg) and gadobenate dimeglumine at 0.1 mmol/kg (0.2 ml/kg). The signal intensity (SI) of the liver parenchyma was independently recorded by two radiologists with subspecialization in abdominal imaging on pre-contrast, 3 min post-contrast, and 5 min post-contrast imaging. Liver enhancement (LE) was calculated as (post-contrast SI - pre-contrast SI) / pre-contrast SI x100. Liver enhancement per ml of Gd (LE/ml) was calculated as LE/ml of contrast used. LE and LE/ml were compared using the Student's t-test.
RESULTS: Patients received an average of 8 ± 1.7 ml of gadopiclenol and 16 ± 3.5 ml of gadobenate dimeglumine. The LE at 3 min (Reader 1, 108 ± 40% vs. 130 ± 69%; Reader 2, 106 ± 94% vs. 104 ± 61%) and 5 min (Reader 1, 91 ± 30% vs. 100 ± 37%; Reader 2, 92 ± 37% vs. 97 ± 40%) was not significantly different (P > 0.3) after injection of gadopiclenol and gadobenate dimeglumine. LE/ml with gadopiclenol was significantly higher than LE/ml with gadobenate dimeglumine at 3 min (Reader 1, 14 ± 0.1% vs. 8 ± 3%; Reader 2, 14 ± 10% vs. 7 ± 3%) and 5 min (Reader 1, 12 ± 4% vs. 6 ± 2%; Reader 2, 12 ± 5% vs. 6 ± 2%) post-contrast administration (P < 0.001).
CONCLUSION: Gadopiclenol demonstrated greater enhancement efficiency per unit volume than gadobenate dimeglumine, though overall enhancement at standard doses was similar.
引用
- Yagobian S, Thangasamy S, Jalluri GD, et al. Intraindividual evaluation of gadopiclenol and gadobenate dimeglumine in liver MRI: impact on enhancement efficiency. Abdom Radiol (NY). 2025. PMID: 41128853. doi:10.1007/s00261-025-05242-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。